Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 2.31 USD 0.43% Market Closed
Market Cap: $791.3m

P/OCF

4.7
Current
64%
Cheaper
vs 3-y average of 13

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
4.7
=
Market Cap
$706m
/
Operating Cash Flow
$167.9m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
4.7
=
Market Cap
$706m
/
Operating Cash Flow
$167.9m

Valuation Scenarios

Goodrx Holdings Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (13), the stock would be worth $6.41 (177% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+242%
Average Upside
211%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 4.7 $2.31
0%
3-Year Average 13 $6.41
+177%
5-Year Average 16 $7.87
+241%
Industry Average 16.1 $7.91
+242%
Country Average 13.3 $6.57
+184%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
US
Goodrx Holdings Inc
NASDAQ:GDRX
787.8m USD 4.7 25.9
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 81.5 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 18.4 53.1
US
Veeva Systems Inc
NYSE:VEEV
26.4B USD 18.6 29
AU
Pro Medicus Ltd
ASX:PME
14.5B AUD 111.4 60.7
JP
M3 Inc
TSE:2413
1T JPY 15.8 20.5
SE
Sectra AB
STO:SECT B
51.8B SEK 63.3 94.2
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD 15.4 42.4
US
Doximity Inc
NYSE:DOCS
4.4B USD 14.1 18.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
18.7B CNY 37.4 -60.8
US
Vocera Communications Inc
F:V00
2.4B EUR 64.1 -328
P/E Multiple
Earnings Growth PEG
US
Goodrx Holdings Inc
NASDAQ:GDRX
Average P/E: 63.5
25.9
72%
0.4
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
29
27%
1.1
AU
Pro Medicus Ltd
ASX:PME
60.7
29%
2.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
94.2
14%
6.7
US
W
Waystar Holding Corp
NASDAQ:WAY
42.4
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.6
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -60.8
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A

Market Distribution

Lower than 89% of companies in the United States of America
Percentile
11th
Based on 9 488 companies
11th percentile
4.7
Low
0 — 8.8
Typical Range
8.8 — 20.1
High
20.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 8.8
Median 13.3
70th Percentile 20.1
Max 3 188 432.5

Goodrx Holdings Inc
Glance View

GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.

GDRX Intrinsic Value
6.58 USD
Undervaluation 65%
Intrinsic Value
Price $2.31
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett